軟通動力(301236.SZ):公司與鯤鵬計算、昇騰計算開展全方位合作,發展算力基礎設施建設,推出軟通訓推一體化平台及昇騰一體機
格隆匯12月22日丨軟通動力(301236.SZ)12月22日在投資者互動平台表示,公司加速構建“算力、算法、數據”三位一體的硬科技創新生態和以AI諮詢、AI模型開發、AI數據治理與安全、AI計算中心運營為核心的專業AI服務能力。在算力和算法層面,公司與鯤鵬計算、昇騰計算開展全方位合作,發展算力基礎設施建設,推出軟通訓推一體化平台及昇騰一體機,並與昇騰共同啟動大模型聯合創新,深度適配不同AI應用場景。 近日,公司以第一中標候選人中標中國電信寧夏公司2023年算力服務集中採購項目標段1,體現了公司在算力相關業務的實力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.